Impact of CYP2D6 polymorphism on tamoxifen therapy: where are we?
Ariana E. Huber-Wechselberger PhD, Paul Niedetzky MD, Irene Aigner, Elisabeth Haschke-Becher MDVolume:
162
Language:
english
Pages:
10
DOI:
10.1007/s10354-012-0118-8
Date:
June, 2012
File:
PDF, 891 KB
english, 2012